JNC-8 Hypertension Clinical Practice Guidelines essay
Clinical Practice Guidelines: JNC-8 Hypertension Guidelines
FNP 591 – Common Illnesses Across the Lifespan
Introduction
Hypertension is defined as having a systolic blood pressure of 130 mmHg or higher or a diastolic blood pressure of 80 mmHg or higher. Blood pressure during systole corresponds to the heart contracting, while blood pressure during diastole corresponds to the heart relaxing. Hypertension is a major risk factor for cardiovascular disease and early death worldwide, and it is extremely avoidable (Mills et al., 2020). Hypertension can result in a variety of severe complications, including atherosclerosis and atrial fibrillation. Over time, the number of people with high blood pressure has significantly increased, as reported by the World Health Organization (2021). In 1990, the number was 675 million, but in 2019, it has risen to over 1.3 billion (WHO, 2021) JNC-8 Hypertension Clinical Practice Guidelines essay.
Although hypertension often doesn’t show early symptoms, it’s important to identify and screen for it early on to prevent serious problems. People should have their blood pressure checked during their yearly or wellness check-ups. Doctors use frequent blood pressure measurements during clinical consultations to identify hypertension. Accurate readings are important to determine the best treatment options based on the patient’s cardiovascular (Jin, 2021).
ORDER A PLAGIARISM-FREE PAPER HERE
Pathophysiology
Multiple variables contribute to the development of hypertension. One example is excessive sodium consumption, which can contribute to an increase in blood volume and blood pressure. Renal, endocrine, vascular, stress, and chemically induced factors are additional causes of hypertension (AlAhmad et al., 2021). Several main risk factors, including age, obesity, smoking, alcohol consumption, and a sedentary lifestyle, contribute to high blood pressure. There are several risk factors that can be modified, and lifestyle changes are usually the first approach to manage them (Guirguis-Blake et al., 2021). Dietary and physical activity modifications can help prevent the progression of hypertension. It is essential to observe that 90% of patients do not have a distinct cause for their hypertension, whereas only 5-10% of patients have secondary hypertension, which is potentially reversible (Guirguis-Blake et al., 2021).
In most cases, hypertension does not present itself with any particular symptoms; nonetheless, endothelial cell damage might lead to the development of problems. A persistently elevated pressure on the walls of blood arteries may result in an increase in peripheral resistance, a reduction in cardiac output, the development of atherosclerosis, and an elevated risk of developing cardiovascular issues. (Iqbal & Jamal, 2022).
Understanding Hypertension
As previously mentioned, in terms of the epidemiology, morbidity, and mortality of hypertension, more than one billion individuals between the ages of 30 and 79 are affected globally (Mills et al., 2020). The World Health Organization estimates that approximately 46% of hypertensive patients will remain undiagnosed in 2022. Unfortunately, only 42% of those who are diagnosed receive treatment for their condition. According to the Centers for Disease Control and Prevention (2023), almost half of adults over 18 have high blood pressure or take medication for it. This condition can lead to serious health problems like stroke and heart disease, which are among the leading causes of death in the United States. In 2018, over 7 million Americans experienced a stroke, and it ranks as the fifth highest cause of death. Furthermore, 4.6% of American adults were diagnosed with coronary artery disease in 2020, with heart disease being the leading cause of death in the US, responsible for over 200,000 fatalities per year (CDC, 2023).
JNC-8 Hypertension Guidelines
To give evidence-based suggestions for the treatment of hypertension (high blood pressure) in adults, the Eighth Joint National Committee (JNC-8) hypertension guidelines were created. These recommendations are based on earlier JNC publications that had a significant impact on the direction of clinical practice. The National Heart, Lung, and Blood Institute (NHLBI) commissioned the creation of the JNC-8 recommendations, which were then created by a group of specialists in cardiovascular and hypertension problems. The intention was to modernize the JNC-7 guidelines, which had been released in 2003. For more than 10 years, the JNC-7 recommendations were crucial in the therapy of hypertension (Al-Ahmad et al., 2021).
The JNC-8 recommendations were released in 2014 with the intention of addressing various important problems and debates in the treatment of hypertension. The JNC 8 recommendations were created using the most recent data, considering studies completed within five years of the submission. The recommendations provide a systematic approach to help primary care doctors manage hypertension while taking into account the patient’s age, race, and blood pressure thresholds as well as concomitant conditions including diabetes mellitus and chronic kidney disease. The ACC/AHA recommendations, which were published in 2017, significantly changed the blood pressure thresholds and treatment objectives, and replaced the JNC 8 guidelines as the most recent (Flack & Adekola, 2020) FNP 591 – Common Illnesses Across the Lifespan JNC-8 Hypertension Clinical Practice Guidelines essay.
It is crucial to note, however, that clinical care of hypertension may need individualization, and the JNC 8 algorithm is meant to address groups of individuals with comparable features. The guidelines emphasize lifestyle modifications as a first-line approach, and the use of specific antihypertensive medications based on patient comorbidities and other factors. To evaluate the effectiveness of the JNC 8 guidelines, it is necessary to analyze statistics and randomized control trials within the population and consider patient outcomes at the primary care level (Al-Makki et al., 2022).
The contentious proposal to treat systolic blood pressure below 150 mm Hg, as well as the following formulation of the 2017 ACC/AHA recommendations, emphasize the need of continual review and tailored treatment choices based on individuals’ particular circumstances and health outcomes. The American College of Cardiology (ACC) and the American Heart Association (AHA) jointly announced revised hypertension recommendations in 2017. When compared to the JNC-8 recommendations, these guidelines made major revisions in blood pressure thresholds and treatment objectives (Mahdavi et al., 2020).
The ACC/AHA hypertension guidelines classified hypertension as 130/80 mm Hg or above, down from 140/90 in JNC-8. Diet, exercise, weight reduction, and salt restriction were stressed as first-line hypertension treatments in the revised recommendations (Flack & Adekola, 2020). They also revised antihypertensive medication guidelines, emphasizing the use of certain drug classes based on compelling rationale and patient characteristics. The latest ACC/AHA hypertension guidelines for adults include diagnosis, assessment, and treatment. They optimize blood pressure regulation and patient care to enhance cardiovascular outcomes. These recommendations provide the latest and most effective hypertension treatment options for healthcare practitioners (Carey et al., 2021). See the figures below:
Figure 1: JNC-8 Hypertension Guidelines Algorithm, & Treatment
(AlAhmad et al., 2021)
Figure 2:
ACC/AHA Hypertension Treatment Guidelines
Figure 4: AHA/ACC Guideline Recommendations by Blood Pressure Category
(Goetsch et al., 2021)
Analysis
United States Demographic
There have been considerable changes in the population and demography since the JNC 8 recommendations were developed in 2013-2014. Healthcare problems such as mental health screenings, vaccines, and preventive medicine have grown in popularity among an aging population. The population of the United States was around 332 million in July 2021, a 0.1% rise from the previous year (Hajjar, 2023). According to the US Census Bureau, the number of people aged 65 and more has climbed from 40.3 million in 2010 to 54.3 million in 2019. Furthermore, the CDC says that non-Hispanic black men are more likely than other ethnic groups to have hypertension FNP 591 – Common Illnesses Across the Lifespan JNC-8 Hypertension Clinical Practice Guidelines essay. This demographic data emphasizes the need of raising hypertension knowledge and controlling it in these risk groups (CDC, 2023).
Changes in Healthcare Reform
Healthcare reform aims to make healthcare providers more accessible, improve the quality of care, and reduce healthcare costs to improve public health. The challenge with healthcare reform in the United States is that it has been a long-standing political debate with few successes and many failures (Ernst et al., 2020). Nevertheless, changes to the American healthcare system are inevitable. When examining healthcare expenditures, the patient should be given the utmost respect and consideration as the primary stakeholder (Harrill & Melon, 2021). To achieve the best possible outcomes for individuals and the public, clinical recommendations must be scrutinized with evidence-based practices in light of demographic changes and healthcare reform in the United States (Carey et al., 2021).
Revision of JNC 8 Hypertension Guidelines
Recent studies have shown that both the Joint National Committee and the ACC/AHA hypertension recommendations are comprehensive and evidence-based, covering all aspects of hypertension, including diagnosis, patient care, and secondary causes. While revisions to these guidelines would need to come from a different medical body like the ACC/AHA, studies have shown that prehypertensive individuals who were treated with antihypertensives such as ACE inhibitors were well tolerated and decreased the incidence of Stage 1 hypertension (Carey et al., 2021) FNP 591 – Common Illnesses Across the Lifespan JNC-8 Hypertension Clinical Practice Guidelines essay.
However, there are positives and downsides associated with both keeping recommendations and updating them. A more aggressive approach like the recommendations proposed by the ACC and AHA would drive up the cost of healthcare and increase the likelihood that antihypertensive medicine may cause unwanted side effects. Previous recommendations, such as JNC 8, had more evidence of inferior patient outcomes, especially in the elderly (Al-Makki et al., 2022).
BUY A PLAGIARISM-FREE PAPER NOW
To come to a solution, it is necessary to find a middle ground between the recommendations of ACC/AHA and JNC 8. This proposal suggests that elderly patients aged 60 years and above should be treated for hypertension if their systolic blood pressure is above 145 mmHg and diastolic blood pressure is 85 mmHg, instead of the usual standard of 140/90 mmHg. The threshold is based on evidence and can lead to a reduction in unwanted side effects associated with antihypertensive medication while still maintaining blood pressure targets for patients who have hypertension. The revision of the hypertensive guidelines will require time for transition, during which all providers will be required to follow through and adapt to the new guidelines.
Strategies for Implementing a New Practice Guideline in Clinical Practice
Our major goal as healthcare providers should be to enhance patient outcomes by using newly approved clinical practice recommendations. Even though each patient’s condition is unique, it is critical to develop practice guidelines that benefit the community. On the other hand, negative attitudes, a lack of resources, and organizational structure might make it difficult to adopt new rules. Clinicians need evidence-based methods, organizational standards, and policy drivers to address these challenges. To ensure widespread acceptance, newly developed recommendations should go through the GRADE collaboration (Grading of suggestion Assessment, Development, and Evaluation), which evaluates the suggestion’s efficacy and the quality of the supporting data. This approach is comparable to that of the Preventative Services Task Force in the United States, which bases its recommendations on solid research methods and patient requirements (Beauchemin et al., 2019) FNP 591 – Common Illnesses Across the Lifespan JNC-8 Hypertension Clinical Practice Guidelines essay.
Conclusion
When introducing new clinical recommendations to a patient population, it is crucial to establish a system of checks and balances to ensure proper compliance. Clinical practice guidelines can be evaluated on various levels, including a provider’s personal experience and expertise. However, factors like the patient population and resource availability can be biased and influence this method. For hypertension patients, JNC 8 guidelines can be used to categorize treatment based on blood pressure, age, race, comorbidities, and medication received (Koc et al., 2020). Treatment compliance can be agreed upon between the healthcare professional and patient, including lifestyle adjustments and medication adherence. Regular blood pressure checks should be performed every three months as part of follow-up care to evaluate efficacy and address concerns. Physician analysis of follow-ups and assessments can determine treatment success based on blood pressure control and patient outcomes.
References
Al-Makki, A., DiPette, D., Whelton, P. K., Murad, M., Mustafa, R. A., Acharya, S., Beheiry, H., Champagne, B., Connell, K., Cooney, M., Ezeigwe, N., Gaziano, T., Gidio, A., Lopez-Jaramillo, P., Khan, U. I., Kumarapeli, V., Moran, A. E., Silwimba, M., Rayner, B.,…Khan, T. (2022). Hypertension pharmacological treatment in adults: A world health organization guideline executive summary.
Hypertension
,
79
(1), 293–301.
https://doi.org/10.1161/hypertensionaha.121.18192
AlAhmad, M., AbuRuz, S., & Beiram, R. (2021). Application of the american college of cardiology(acc/aha) 2017 guideline for the management ofhypertension in adults and comparison with the2014 eighth joint national committee guideline.
Journal of the Saudi Heart Association
,
33
(1), 16–25.
https://doi.org/10.37616/2212-5043.1233
Beauchemin, M., Cohn, E., & Shelton, R. C. (2019). Implementation of clinical practice guidelines in the health care setting.
Advances in Nursing Science
,
42
(4), 307–324.
https://doi.org/10.1097/ans.0000000000000263
Campbell, N. R., Paccot Burnens, M., Whelton, P. K., Angell, S. Y., Jaffe, M. G., Cohn, J., Espinosa Brito, A., Irazola, V., Brettler, J. W., Roccella, E. J., Maldonado Figueredo, J., Rosende, A., & Ordunez, P. (2022). 2021 world health organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the americas.
The Lancet Regional Health – Americas
,
9
, 100219.
https://doi.org/10.1016/j.lana.2022.100219
Carey, R. M., Wright, J. T., Jr, Taler, S. J., & Whelton, P. K. (2021). Guideline-Driven Management of Hypertension An Evidence-Based Update.
Circulation Research
,
2021
(128), 827–846.
https://doi.org/10.1161/CIRCRESAHA
Centers for Disease Control and Prevention. (2023, February 14).
Faststats
. Retrieved June 14, 2023, from
https://www.cdc.gov/nchs/fastats/hypertension.htm
Ernst, M. E., Chowdhury, E. K., Beilin, L. J., Margolis, K. L., Nelson, M. R., Wolfe, R., Tonkin, A. M., Ryan, J., Woods, R. L., McNeil, J. J., & Reid, C. M. (2020). Long-term blood pressure variability and risk of cardiovascular disease events among community-dwelling elderly.
Hypertension
,
76
(6), 1945–1952.
https://doi.org/10.1161/hypertensionaha.120.16209
FNP 591 – Common Illnesses Across the Lifespan JNC-8 Hypertension Clinical Practice Guidelines essay
Flack, J. M., & Adekola, B. (2020). Blood pressure and the new acc/aha hypertension guidelines.
Trends in Cardiovascular Medicine
,
30
(3), 160–164.
https://doi.org/10.1016/j.tcm.2019.05.003
Goetsch, M. R., Tumarkin, E., Blumenthal, R. S., & Kalra, P. R. (2021, June 21).
New guidance on blood pressure management in low-risk adults with stage 1 hypertension – american college of cardiology
. American College of Cardiology. Retrieved June 14, 2023, from
https://www.acc.org/Latest-in-Cardiology/Articles/2021/06/21/13/05/New-Guidance-on-BP-Management-in-Low-Risk-Adults-with-Stage-1-HTN
Guirguis-Blake, J. M., Evans, C. V., Webber, E. M., Coppola, E. L., Perdue, L. A., & Weyrich, M. (2021). Screening for hypertension in adults.
JAMA
,
325
(16), 1657.
https://doi.org/10.1001/jama.2020.21669
Hajjar, I. (2023, March 16).
Hypertension
. Retrieved June 14, 2023, from
https://www.who.int/news-room/fact-sheets/detail/hypertension
Harrill, W. C., & Melon, D. E. (2021). A field guide to u.s. healthcare reform: The evolution to value‐based healthcare.
Laryngoscope Investigative Otolaryngology
,
6
(3), 590–599.
https://doi.org/10.1002/lio2.575
Iqbal, A. M., & Jamal, S. F. (2022, July 4).
Essential Hypertension
. National Center for Biotechnology Information. Retrieved June 14, 2023, from
https://www.ncbi.nlm.nih.gov/books/NBK539859/
Jin, J. (2021). Screening for hypertension in adults.
JAMA
,
325
(16), 1688.
https://doi.org/10.1001/jama.2021.5288
Koc, E., Aksoy, H., Ayhan Baser, D., Baydar Artantas, A., Kahveci, R., & Cihan, F. (2020). Evaluation of clinical practice guideline quality: Comparison of two appraisal tools.
International Journal for Quality in Health Care
,
32
(10), 663–670.
https://doi.org/10.1093/intqhc/mzaa129
Mahdavi, M., Parsaeian, M., Mohajer, B., Modirian, M., Ahmadi, N., Yoosefi, M., Mehdipour, P., Djalalinia, S., Rezaei, N., Haghshenas, R., Pazhuheian, F., Madadi, Z., Sabooni, M., Razi, F., Samiee, S., & Farzadfar, F. (2020). Insight into blood pressure targets for universal coverage of hypertension services in iran: The 2017 acc/aha versus jnc 8 hypertension guidelines.
BMC Public Health
,
20
(1).
https://doi.org/10.1186/s12889-020-8450-1
Mills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension.
Nature Reviews Nephrology
,
16
(4), 223–237.
https://doi.org/10.1038/s41581-019-0244-2
World Health Organization. (2021, August 25).
More than 700 million people with untreated hypertension
. Retrieved June 14, 2023, from
https://www.who.int/news/item/25-08-2021-more-than-700-million-people-with-untreated-hypertension
FNP 591 – Common Illnesses Across the Lifespan JNC-8 Hypertension Clinical Practice Guidelines essay